(TCAF) T. Rowe Price - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • • Large Blend
TCAF: Equity, Stocks, Large, US, Companies, Technology, Healthcare
T. Rowe Price Exchange-Traded Funds, Inc. (NYSE ARCA: TCAF) is a U.S.-based ETF categorized under Large Blend, focusing on large-cap U.S. companies. It typically invests at least 80% of its net assets in equity securities, often concentrating on sectors like information technology and healthcare.
As a non-diversified fund, TCAF can allocate a significant portion to specific sectors, which may heighten sector-specific risks. T. Rowe Price, known for its active management approach, seeks long-term capital growth through fundamental research.
With an AUM of $3.3777 billion and a net expense ratio of 0.34%, TCAF offers exposure to large-cap equities at a moderate cost. This makes it a viable option for investors seeking diversified large-cap exposure with active management benefits.
Prospective investors should note the absence of P/E and other multiples, typical for ETFs, and consider the concentration risks due to its non-diversified strategy.
Additional Sources for TCAF ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
TCAF ETF Overview
| Market Cap in USD | 3,484m |
| Category | Large Blend |
| TER | 0.31% |
| IPO / Inception | 2023-06-14 |
TCAF ETF Ratings
| Growth 5y | 86.2% |
| Fundamental | - |
| Dividend | 49.8% |
| Rel. Strength Industry | -4.03 |
| Analysts | - |
| Fair Price Momentum | 30.61 USD |
| Fair Price DCF | - |
TCAF Dividends
| Dividend Yield 12m | 0.44% |
| Yield on Cost 5y | 0.57% |
| Annual Growth 5y | 42.91% |
| Payout Consistency | 100.0% |
TCAF Growth Ratios
| Growth Correlation 3m | 32.6% |
| Growth Correlation 12m | 95.6% |
| Growth Correlation 5y | 96.9% |
| CAGR 5y | 18.59% |
| CAGR/Max DD 5y | 2.11 |
| Sharpe Ratio 12m | 0.91 |
| Alpha | -2.78 |
| Beta | 0.88 |
| Volatility | 10.51% |
| Current Volume | 882.1k |
| Average Volume 20d | 799.1k |
As of February 22, 2025, the stock is trading at USD 33.83 with a total of 882,140 shares traded.
Over the past week, the price has changed by -1.34%, over one month by -1.40%, over three months by +0.37% and over the past year by +17.28%.
Yes. Based on ValueRay Analyses, T. Rowe Price (NYSE ARCA:TCAF) is currently (February 2025) a good stock to buy. It has a ValueRay Growth Rating of 86.21 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of TCAF as of February 2025 is 30.61. This means that TCAF is currently overvalued and has a potential downside of -9.52%.
T. Rowe Price has no consensus analysts rating.
According to ValueRays Forecast Model, TCAF T. Rowe Price will be worth about 36.7 in February 2026. The stock is currently trading at 33.83. This means that the stock has a potential upside of +8.57%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 36.7 | 8.6% |